Literature DB >> 27145781

Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature.

Takuro Kuriyama1, Noriaki Kawano2, Kiyoshi Yamashita2, Ikuo Kikuchi2.   

Abstract

Primary bone lymphomas comprise <1 % of all malignant lymphomas, and there have been only a limited number of reports on primary adult T-cell leukemia/lymphoma (ATLL) of bone. Here, we report two cases of primary ATLL of bone. The first case was a 41-year-old woman with multiple bone tumors. She was diagnosed with ATLL of the skull through biopsy and treated with chemotherapy. Although the bone lesions showed transient improvement, the subsequent central nervous system (CNS) invasion of ATLL occurred and she died 7 months after diagnosis. The second case was a 65-year-old man with right coxodynia. He was diagnosed with ATLL through right femoral biopsy, and the lesion improved with chemotherapy. However, CNS invasion of ATLL developed during chemotherapy, and he died 10 months after diagnosis. Both the patients with primary ATLL of the bone reported here experienced CNS invasion. Thus, ATLL treatment should aim to prevent CNS invasion at an early stage.

Entities:  

Keywords:  Adult T-cell leukemia/lymphoma; Central nervous system invasion; Primary bone lymphoma

Mesh:

Year:  2016        PMID: 27145781     DOI: 10.1007/s12185-016-2015-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).

Authors:  Carlo Messina; Andrés J M Ferreri; Silvia Govi; Marta Bruno-Ventre; Elías A Gracia Medina; David Porter; John Radford; Dae S Heo; Hee Y Park; Barbara Pro; Jayasingham Jayamohan; Carlo Visco; Lydia Scarfò; Emanuele Zucca; Mary Gospodarowicz; David Christie
Journal:  Br J Haematol       Date:  2014-01-02       Impact factor: 6.998

2.  Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center.

Authors:  Alexios Matikas; Alexandros Briasoulis; Ifigeneia Tzannou; Dimitra Oikonomopoulou; Maria Bakiri; Themis Karmiris; Nikolaos Harhalakis
Journal:  Acta Haematol       Date:  2013-08-31       Impact factor: 2.195

3.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

Review 4.  Adult T cell leukemia lymphoma (ATL) localized in the right tibial bone.

Authors:  M Tabata; H Takahashi; T Izumi; N Komatsu; J Tsunoda; M Yoshida; S Nakama; K Kuriki; K Saito; K Hatake; Y Miura
Journal:  Leuk Lymphoma       Date:  1999-09

5.  The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone.

Authors:  S Govi; D Christie; C Messina; M Bruno Ventre; E A Gracia Medina; D Porter; J Radford; D Seog Heo; Y Park; G Martinelli; E Taylor; H Lucraft; V Ballova; E Zucca; M Gospodarowicz; A J M Ferreri
Journal:  Ann Oncol       Date:  2013-11-28       Impact factor: 32.976

6.  Primary adult T-cell leukemia/lymphoma of bone.

Authors:  Tomoko Hara; Shingo Wakatsuki; Shuji Ozaki; Masahiro Abe; Masaaki Kosaka
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

7.  Lymphomas of the bone: a pathological and clinical study of 54 cases.

Authors:  Umberto Gianelli; Carlo Patriarca; Alessia Moro; Maurilio Ponzoni; Roberto Giardini; Maura Massimino; Rosa Maria Alfano; Elisabetta Armiraglio; Paolo Nuciforo; Silvano Bosari; Guido Coggi; Antonina Parafioriti
Journal:  Int J Surg Pathol       Date:  2002-10       Impact factor: 1.271

8.  R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

Authors:  Alejandro Martín; Eulogio Conde; Montserrat Arnan; Miguel A Canales; Guillermo Deben; Juan M Sancho; Rafael Andreu; Antonio Salar; Pedro García-Sanchez; Lourdes Vázquez; Sara Nistal; María-José Requena; Eva M Donato; José A González; Angel León; Concepción Ruiz; Carlos Grande; Eva González-Barca; María-Dolores Caballero
Journal:  Haematologica       Date:  2008-10-22       Impact factor: 9.941

Review 9.  Primary adult T cell leukemia of bone: two patients with primary bone lesion showing monoclonal integration of HTLV-I proviral DNA.

Authors:  S Takemoto; M Matsuoka; K Sakata; H Matsuzaki; K Akagi; K Yamaguchi; K Takatsuki
Journal:  Leukemia       Date:  1996-02       Impact factor: 11.528

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  4 in total

1.  Diffuse large B-cell lymphoma with a bulky mass in the cranial vault.

Authors:  Minoru Kanaya; Tomoyuki Endo; Daigo Hashimoto; Shogo Endo; Ryo Takemura; Kohei Okada; Kanako C Hatanaka; Yoshihiro Matsuno; Takanori Teshima
Journal:  Int J Hematol       Date:  2017-04-07       Impact factor: 2.490

2.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

3.  Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.

Authors:  H Kato; M Koga; H Kobayashi; H Maki; M Ikemura; M Kurokawa; M Nangaku; N Makita; N Ito
Journal:  Osteoporos Int       Date:  2020-10-31       Impact factor: 4.507

4.  Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.

Authors:  Nicole A Kohart; Said M Elshafae; Wachirapan Supsahvad; Aylin Alasonyalilar-Demirer; Amanda R Panfil; Jingyu Xiang; Wessel P Dirksen; Deborah J Veis; Patrick L Green; Katherine N Weilbaecher; Thomas J Rosol
Journal:  J Bone Oncol       Date:  2019-08-20       Impact factor: 4.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.